AbCellera COO Lecault transitions to CTO; COO role dissolved

AbCellera Biologics Inc.

Effective Feb 18, 2025, Veronique Lecault moved from COO to CTO.
Change agreed mutually, not due to any disagreement with company.
COO position will not be filled and is dissolved.
Lecault remains a director on the Board of Directors.

item 8.01

AbCellera Biologics Inc. filing history →

Source: SEC EDGAR

accession 0001628280-25-005983

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.